再生医学的转化与商业化

lcyndi

看不了啊！！！！

xuyan80219

看不了啊，楼主可否发一份啊，感激感激！
# x$ Y5 E0 S) Sxuyan80219@gmail.com

simonx

Can you send me a copy? Thaniks.! v$ v; N9 T! b) o1 V* K0 _$ {
siiimon@ sohu.com

simonx

Can you send me a copy? Thaniks.
5 s: Z+ v7 N& t+ Y5 Hsiiimon@ sohu.com

bigship

楼主可以也给我发一份不 ; i1 U6 P6 ~2 B! f& q$ L* R
soulstriker@126.com& l+ B/ R3 T& N3 h& I/ t: V
thanks

tpwang

botizhou 发表于 2010-10-15 16:51

- B3 u' v3 b+ P& ]( q
其实这是一篇系列文章的introduction，全部系列文章可以在网上看到并下载：( S  D" z6 v0 k
http://rsif.royalsocietypublishi ... 7/Suppl_6/S675.full7 ]" M1 v$ R0 V" e1 v0 J1 r
& N. \. Y: I; A2 C
如果对特定文章感兴趣，可以根据系列文章列表选择下载：
: v* G. d! z7 A" F' Y
+ |3 K4 g: c$ d/ |& I* @Abdulrazzak H., Moschidou D., Jones G., Guillot P. V.2010 Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J. R. Soc. Interface 7, S689–S706. (doi:10.1098/rsif.2010.0347.focus)Abstract/FREE Full Text↵
+ T* T* V# h! D4 HBravery C. A.2010 Regulating interface science healthcare products: myths and uncertainties. J. R. Soc. Interface 7, S789–S795. (doi:10.1098/rsif.2010.0442.focus)Abstract/FREE Full Text↵/ u- f: [6 o. I4 `& ^6 a
Jamil-Copley S., Kanagaratnam P.2010 Stroke in atrial fibrillation—hope on the horizon? J. R. Soc. Interface 7, S765–S769. (doi:10.1098/rsif.2010.0344.focus)Abstract/FREE Full Text↵, a5 d, F' h  c. T. G
Kelleher C. M., Vacanti J. P.2010 Engineering extracellular matrix through nanotechnology. J. R. Soc. Interface 7, S717–S729. (doi:10.1098/rsif.2010.0345.focus)Abstract/FREE Full Text↵  q) u- m' [# w+ r1 L3 r1 a
Kooreman N. G., Wu J. C.2010 Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J. R. Soc. Interface 7, S753–S763. (doi:10.1098/rsif.2010.0353.focus)Abstract/FREE Full Text↵9 I9 [9 ?  r# Q8 \* V
Kureshi A., Cheema U., Alekseeva T., Cambrey A., Brown R.2010 Alignment hierarchies: engineering architecture from the nanometre to the micrometre scale. J. R. Soc. Interface 7, S707–S716. (doi:10.1098/rsif.2010.0346.focus)Abstract/FREE Full Text↵0 i7 v0 }- C/ ^# ?- J1 ]3 E6 Q- m
Nerem R. M.2010 Regenerative medicine: the emergence of an industry. J. R. Soc. Interface 7, S771–S775. (doi:10.1098/rsif.2010.0348.focus)Abstract/FREE Full Text↵
! g& e( k) Q0 l6 B8 ]# @% zPolak D. J.2010 Regenerative medicine. Opportunities and challenges: a brief overview. J. R. Soc. Interface 7, S777–S781. (doi:10.1098/rsif.2010.0362.focus)Abstract/FREE Full Text↵
+ ?1 ?) H. P( i3 B- q2 h$ cPrescott C.2010 Regenerative nanomedicines: an emerging investment prospective? J. R. Soc. Interface 7, S783–S787. (doi:10.1098/rsif.2010.0351.focus)Abstract/FREE Full Text↵+ d: B& X& h& H$ T& u7 J. S+ A
Stephenson E., Ogilvie C. M., Patel H., Cornwell G., Jacquet L., Kadeva N., Braude P., Ilic D.2010 Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J. R. Soc. Interface 7, S677–S688. (doi:10.1098/rsif.2010.0343.focus)Abstract/FREE Full Text↵
6 G: M' s3 A2 S! |Watt S. M., Athanassopoulos A., Harris A. L., Tsaknakis G.2010 Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J. R. Soc. Interface 7, S731–S751. (doi:10.1098/rsif.2010.0377.focus)Abstract/FREE Full Text